U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
100891100891Relative Effectiveness of Schizophrenia Therapy StudyCompletedNo Results AvailableSchizophrenia|Bipolar DisorderGenetic: SULT4A1-1 genetic testhttps://ClinicalTrials.gov/show/NCT01245348
100892100892Bone Marrow Aspirate Concentrate (BMAC) for Treatment of Critical Limb Ischemia (CLI)Active, not recruitingNo Results AvailableCritical Limb IschemiaDevice: BMAC injection|Device: Placebo injectionhttps://ClinicalTrials.gov/show/NCT01245335
100893100893Treatment of Bacterial Vaginosis Combined With Human LactobacilliCompletedNo Results AvailableBacterial VaginosisDrug: lactobacillihttps://ClinicalTrials.gov/show/NCT01245322
100894100894Endometrial Scratching Prior to Controlled Ovarian Stimulation (COH) in Women Undergoing In-vitro Fertilization With Previous IVF FailureCompletedNo Results AvailableInfertilityProcedure: scratching|Procedure: A PLACEBO PROCEDUREhttps://ClinicalTrials.gov/show/NCT01245309
100895100895Early Versus Delayed Cord Clamping at Term: Outcomes in Swedish InfantsCompletedNo Results AvailableIron Deficiency|Neonatal HyperbilirubinemiaProcedure: Timing of clamping the umbilical cordhttps://ClinicalTrials.gov/show/NCT01245296
100896100896Resistance Exercise and Knee Osteoarthritis Pain, Functional Impairment and Cartilage TurnoverCompletedHas ResultsKnee OsteoarthritisOther: normal activities and clinical care|Other: Concentric Focused Resistance Exercise|Other: Eccentric Focused Resistance Exercisehttps://ClinicalTrials.gov/show/NCT01245283
100897100897A Single Supplement of a Standardised Bilberry Extract Modifies Glycaemic ResponseCompletedHas ResultsType 2 DiabetesDietary Supplement: Bilberry capsule first, then control cap|Dietary Supplement: Control capsule first then bilberry caphttps://ClinicalTrials.gov/show/NCT01245270
100898100898Effects of Prednisolone and Pentoxifylline on the Regulation of Urea Synthesis in Alcoholic HepatitisRecruitingNo Results AvailableAlcoholic Hepatitishttps://ClinicalTrials.gov/show/NCT01245257
100899100899Morphine Modulation of The Brain's Pain MatrixCompletedNo Results AvailablePainDrug: Morphine|Other: orange juicehttps://ClinicalTrials.gov/show/NCT01245244
100900100900Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid LeukemiaActive, not recruitingNo Results AvailableLeukemiaGenetic: protein expression analysis|Genetic: western blotting|Other: flow cytometry|Other: laboratory biomarker analysis|Other: medical chart reviewhttps://ClinicalTrials.gov/show/NCT01245231
100901100901Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast CancerCompletedNo Results AvailableHER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Unspecified Adult Solid Tumor, Protocol SpecificDrug: Akt inhibitor MK2206|Drug: lapatinib ditosylate|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01245205
100902100902Study of Panobinostat (LBH589) in Patients With Sickle Cell DiseaseRecruitingNo Results AvailableSickle Cell DiseaseDrug: panobinostathttps://ClinicalTrials.gov/show/NCT01245179
100903100903A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes MellitusRecruitingNo Results AvailableThe Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg|Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in|Subjects With Type 2 Diabetes Mellitus.Drug: Acarbose|Drug: Metformin/Acarbosehttps://ClinicalTrials.gov/show/NCT01245166
100904100904Rectal Balloon Training in Female Urinary IncontinenceRecruitingNo Results AvailableUrinary IncontinenceOther: Rectal Balloon Training|Other: Pelvic floor muscle training (PFMT)https://ClinicalTrials.gov/show/NCT01245153
100905100905Efficacy of Alitretinoin Treatment in Patients With Pustular Form of PsoriasisCompletedNo Results AvailablePsoriasisDrug: alitretinoin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01245140
100906100906Ilaris (Canakinumab) in the Schnitzler SyndromeCompletedNo Results AvailableSchnitzler SyndromeDrug: Ilarishttps://ClinicalTrials.gov/show/NCT01245127
100907100907Tübingen High Altitude Ophthalmology StudyCompletedNo Results AvailableAltitude|Hypoxiahttps://ClinicalTrials.gov/show/NCT01245114
100908100908Addition of Raltegravir to Established Antiretroviral Suppressive TherapyActive, not recruitingNo Results AvailableHIVDrug: Raltegravir|Drug: Raltegravirhttps://ClinicalTrials.gov/show/NCT01245101
100909100909Chondroitin Sulfate for Crohn's DiseaseWithdrawnNo Results AvailableCrohn's DiseaseDrug: chondroitin sulfatehttps://ClinicalTrials.gov/show/NCT01245088
100910100910Deep Brain Stimulation of the Nucleus Accumbens as a Novel Treatment in Severe Opioid AddictionRecruitingNo Results AvailableAddictionOther: Deep brain stimulation|Other: Placebohttps://ClinicalTrials.gov/show/NCT01245075
100911100911GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive MelanomaActive, not recruitingHas ResultsMelanomaDrug: GSK1120212|Drug: Chemotherapyhttps://ClinicalTrials.gov/show/NCT01245062
100912100912Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old ChildrenCompletedNo Results AvailableAcellular Pertussis|Poliomyelitis|Tetanus|DiphtheriaBiological: Boostrix PolioTM|Biological: RepevaxTM|Biological: PriorixTMhttps://ClinicalTrials.gov/show/NCT01245049
100913100913Efficacy of Antituberculous Therapy in Management of SarcoidosisCompletedNo Results AvailableSarcoidosis|TuberculosisDrug: Antituberculous therapy along with steroidshttps://ClinicalTrials.gov/show/NCT01245036
100914100914Adhesiolysis in Chronic Abdominal PainWithdrawnNo Results AvailableChronic Abdominal PainProcedure: Laparoscopic adhesiolysis|Procedure: Placebo-surgeryhttps://ClinicalTrials.gov/show/NCT01245023
100915100915Water Beverage Intervention Trial for Reducing Risk Factors of Metabolic Syndrome in Young Mexican Free Living WomenCompletedNo Results AvailableMetabolic SyndromeOther: Water|Other: Educationhttps://ClinicalTrials.gov/show/NCT01245010
100916100916Evaluation of Implants Placed Immediately or Delayed Into Extraction SitesCompletedNo Results AvailableDental CariesProcedure: Dental Implanthttps://ClinicalTrials.gov/show/NCT01244997
100917100917A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With AsthmaCompletedHas ResultsAsthmaDrug: Fluticasone Furoate/GW642444 Inhalation Powder|Drug: Fluticasone Furoate Inhalation Powderhttps://ClinicalTrials.gov/show/NCT01244984
100918100918Exercise and Acarbose in Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus Type 2Drug: Acarbose|Behavioral: Exercise|Other: Exercise + Acarbosehttps://ClinicalTrials.gov/show/NCT01244971
100919100919Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisBiological: Rituximab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01244958
100920100920Lactobacillus Reuteri DSM 17938 in Functional ConstipationCompletedNo Results AvailableFunctional ConstipationDietary Supplement: L. reuteri DSM 17938|Other: Placebo Grouphttps://ClinicalTrials.gov/show/NCT01244945

* Görseller ve İçerik tekif hakkına sahip olabilir